Marion Procter
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 32
- HER2/EGFR in Cancer Research 30
- Peptidase Inhibition and Analysis 12
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 2
-
- Breast Cancer Treatment Studies 16
- Co-authors
- Martine Piccart (24 shared papers)Richard D. Gelber (19 shared papers)Evandro de Azambuja (22 shared papers)Thomas Suter (2 shared papers)Mitch Dowsett (11 shared papers)Giuseppe Viale (8 shared papers)Brian Leyland‐Jones (8 shared papers)Michael Untch (9 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (5 papers)Annals of Oncology (4 papers)The Lancet (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- BelgiumSwitzerlandItaly
In The Last Decade
Marion Procter
31 papers receiving 2.7k citations
Marion Procter's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 2.3k
- Cancer Research 926
- Radiology, Nuclear Medicine and Imaging 849
- Cardiology and Cardiovascular Medicine 683
- Pulmonary and Respiratory Medicine 593
Countries citing papers authored by Marion Procter
This map shows the geographic impact of Marion Procter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Procter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Procter more than expected).
Fields of papers citing papers by Marion Procter
This network shows the impact of papers produced by Marion Procter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Procter. The network helps show where Marion Procter may publish in the future.
Co-authors
The 25 scholars most cited alongside Marion Procter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer Hit paper breakdown → | 2017 | 918 |
| 2 | 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial Hit paper breakdown → | 2017 | 688 |
| 3 | 2007 | 399 | |
| 4 | 2014 | 182 | |
| 5 | 2010 | 179 | |
| 6 | 2009 | 146 | |
| 7 | 2019 | 40 | |
| 8 | 2012 | 32 | |
| 9 | 2013 | 30 | |
| 10 | 2022 | 30 | |
| 11 | 2013 | 22 | |
| 12 | 2012 | 20 | |
| 13 | 2009 | 17 | |
| 14 | 2017 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2021 | 5 | |
| 18 | 2007 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2019 | 4 |
About Marion Procter
Marion Procter is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (30 papers), Breast Cancer Treatment Studies (16 papers), Peptidase Inhibition and Analysis (12 papers), Cancer Treatment and Pharmacology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Advanced Breast Cancer Therapies (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (926 citations), Radiology, Nuclear Medicine and Imaging (849 citations), Cardiology and Cardiovascular Medicine (683 citations) and Pulmonary and Respiratory Medicine (593 citations). Marion Procter has collaborated with scholars based in Belgium, Switzerland and Italy. Frequent co-authors include Martine Piccart, Richard D. Gelber, Evandro de Azambuja, Thomas Suter, Mitch Dowsett, Giuseppe Viale, Brian Leyland‐Jones, Michael Untch, David Cameron and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, The Lancet and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.